Most menopausal women experience vasomotor symptoms with bothersome symptoms
often lasting longer than one decade. Hormone therapy (HT) represents the most effective …

Venous thromboembolism (VTE) including pulmonary embolism (PE) and deep vein
thrombosis (DVT) is one of the leading causes of preventable cardiovascular disease in the …

Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …

Objective: The objective of this document is to generate a practice guideline for the
management and treatment of symptoms of the menopause. Participants: The Treatment of …

Ten years after the first results from the Women's Health Initiative (WHI) trial were published,
it seems that the atmosphere around the issue of menopausal hormone therapy (MHT) is …

The past decade has seen marked fluctuations in opinions concerning the merits and risks
of postmenopausal hormone replacement therapy (HRT). In July 2002, menopause …

Background: Menopausal hormone therapy is widely used to alleviate climacteric symptoms
but may increase the risk of venous and arterial vascular events. Objective: The objective …

Estrogen and progestins have been used by millions of women as effective combined
contraceptives. The safety of hormonal contraceptives has been documented by years of …

AACE= American Association of Clinical Endocrinologists; BEL= best evidence level; CAD=
coronary artery disease; CCS= consecutive case series; CEE= conjugated equine estrogen; …

Introduction Hormone therapy (HT) is an effective treatment for climacteric symptoms.
Nevertheless, combined estrogen-progestin therapy and the oral route seem to entail higher …